Polaris Inc. logo PII - Polaris Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 3
HOLD 24
SELL 0
STRONG
SELL 0
| PRICE TARGET: $72.00 DETAILS
HIGH: $83.00
LOW: $66.00
MEDIAN: $67.00
CONSENSUS: $72.00
UPSIDE: 6.15%

Stock News

Needham says Polaris Forge 3 lease agreement could drive Applied Digital stock higher

Needham says Polaris Forge 3 lease agreement could drive Applied Digital stock higher

Applied Digital (APLD) rallied on May 21 after Needham said the firm's 15-year lease agreement for 300 MW of critical capacity at its advanced Polaris Forge 3 data center campus in North Dakota will drive its share price higher. In a research note this morning, analyst John Todaro told clients that the multi-billion-dollar hyper-scaler commitment offers exceptional visibility and predictability into future revenue.

May 21, 2026 10:57 AM • invezz.com
Polaris Publishes 2025 Geared For Good Report

Polaris Publishes 2025 Geared For Good Report

Annual report highlights progress across product innovation, environmental stewardship, community impact and employee development MINNEAPOLIS, May 21, 2026 /PRNewswire/ -- Polaris Inc. (NYSE: PII) today released its 2025 Geared For Good Report. The annual report highlights Polaris' ongoing efforts to support its people, riders, communities and the outdoors while advancing toward its 2035 environmental goals.

May 20, 2026 08:03 PM • prnewswire.com
Encoded Therapeutics Presents New Clinical Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the ASGCT 2026 Presidential Symposium

Encoded Therapeutics Presents New Clinical Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the ASGCT 2026 Presidential Symposium

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #ASGCT2026--Encoded Therapeutics, Inc. (“Encoded”), a clinical‑stage biotechnology company developing precision genetic medicines for severe neurological disorders, today will present an expanded dataset from the ongoing POLARIS Phase 1/2 trials of ETX101, its investigational AAV9‑based gene regulation therapy designed as a one‑time, disease‑modifying treatment for SCN1A+ Dravet syndrome. The update includes additional patients, early data from the top dose lev.

May 13, 2026 02:00 AM • businesswire.com
Behavox Extends Polaris Trade Surveillance to Prediction Markets, Expanding Risk Coverage to 10 Asset Classes

Behavox Extends Polaris Trade Surveillance to Prediction Markets, Expanding Risk Coverage to 10 Asset Classes

LONDON & MONTREAL--(BUSINESS WIRE)--Behavox, an AI company providing unified controls frameworks for financial institutions, today announced that Polaris, its trade surveillance platform, now covers prediction markets as a new asset class — bringing Polaris's out-of-the-box risk coverage to 10 asset classes. Prediction markets coverage is available in beta to existing Polaris customers immediately, with general availability scheduled for summer 2026. "We are getting consistent feedback from cus.

May 12, 2026 04:00 AM • businesswire.com
Polaris Renewable Energy Announces Approval of SO1 Agreement by FOMB

Polaris Renewable Energy Announces Approval of SO1 Agreement by FOMB

TORONTO, ON / ACCESS Newswire / May 12, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company"), is pleased to announce that, on May 8, 2026, the Financial Oversight and Management Board of Puerto Rico ("FOMB") approved the Battery Energy Storage System ("BESS") Standard Offer Agreement ("SO1 Agreement"). The approval of the FOMB completes the three-steps approval process for the SO1 Agreement, following prior regulatory approvals obtained from the Puerto Rico Energy Bureau ("PREB") and the Governing Board of the Puerto Rico Electric Power Authority ("PREPA").

May 12, 2026 03:50 AM • accessnewswire.com
Polaris Renewable Energy Announces Q1 2026 Results

Polaris Renewable Energy Announces Q1 2026 Results

TORONTO, ON / ACCESS Newswire / May 7, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to report its financial and operating results for the quarter ended March 31, 2026. This earnings release should be read in conjunction with the Company's consolidated financial statements and management's discussion and analysis, which are available on the Company's website at www.PolarisREI.com and have been posted on SEDAR+ at www.sedarplus.ca.

May 07, 2026 03:50 AM • accessnewswire.com
Canagold: New Polaris Gold-Antimony Project Recognized as a Priority Project by British Columbia

Canagold: New Polaris Gold-Antimony Project Recognized as a Priority Project by British Columbia

Vancouver, British Columbia--(Newsfile Corp. - May 1, 2026) - Canagold Resources Ltd. (TSX: CCM) (OTCQB: CRCUF) (FSE: CANA) (the "Company" or "Canagold") is pleased to announce that the New Polaris Gold Antimony Project has been added to the Government of British Columbia ("the Province") list of priority major projects, as outlined in the Province's recent Look West economic update published on April 29, 2026.

May 01, 2026 03:00 AM • newsfilecorp.com
Polaris Announces Spring 2026 TRAILS GRANTS as Program Marks 20 Years

Polaris Announces Spring 2026 TRAILS GRANTS as Program Marks 20 Years

More than $125,000 awarded to 14 off-road and snowmobile riding clubs across the U.S. and Canada as Polaris surpasses $4 million in total giving since the program's inception MINNEAPOLIS, April 23, 2026 /PRNewswire/ -- Today, Polaris Inc. (NYSE: PII), the global leader in powersports, announced the recipients of its Spring 2026 TRAILS GRANTS, awarding more than $125,000 to 14 off‑road and snowmobile organizations to support riders and riding areas across the United States and Canada. In 2026, the TRAILS GRANTS program marks its 20th anniversary, a milestone year that coincides with Polaris surpassing $4 million in total giving since the program launched in 2006.

Apr 23, 2026 08:03 AM • prnewswire.com

Price Targets